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Abstract
The positive reinforcing properties of addictive drugs have a primary role in the development of drug dependence. In the field of 
opiates, great attention has been given to this phenomenon, as well as to the negative properties eliciting craving and inducing relapse 
during withdrawal. This study was designed to evaluate whether elevated plus-maze (EPM) experienced rats withdrawn from low 
doses of subcutaneous (s.c.) morphine (10 mg/kg), in which a high anxiety level is the most prominent withdrawal symptom, acquire 
place preference when submitted to a conflict paradigm in which drug effects are paired with an aversive context: the distal part of the 
open arms of an EPM. Both the anxiety test and place preference conditioning were measured in the same apparatus, a biased version 
of the plus-maze. In order to verify the influence of previous EPM spatial learning on the performance of morphine-withdrawn rats, half 
the animals in this study experienced the EPM prior to treatment. Additional groups were also tested under the influence of morphine 
effects. The effects of the treatments were quantified through the analysis of three types of measures: anxiety was inferred from the 
use of the conventional measures (percentage of entries and time spent in the open-arms) and risk-assessment behaviours (frequency 
of stretched-attending postures – SAP, and time spent at the centre of the maze). Place preference conditioning was evaluated through 
analysis of the number of entries, total time spent and distance run in the open-arm extremities, which is where the animals were 
conditioned. The number of closed-arm entries was taken as an index of locomotor activity. Our results showed that (i) EPM naïve 
rats pre-treated with morphine did not develop place preference, behaving like control rats; (ii) rats that had previous experience in 
the EPM showed no changes in open-arm avoidance on the second exposure, when compared with rats naïve for this condition; (iii) 
previous spatial learning of the EPM contextual cues was, in fact, a requirement for anxiety-inducing place preference for the open-
arms in morphine-withdrawn rats and, (iiii) conditioned place preference was achieved both in rats under the effects of morphine and 
in withdrawal, probably through the influence of the positive or negative reinforcing effects promoted by the presence or absence of the 
drug in the central nervous system. Keywords: drug abuse, opiate withdrawal, anxiety, place-preference, elevated plus-maze.
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Introduction
It has been suggested that the positive reinforcing 
properties of addictive drugs have a primary role in 
the development of drug dependence (Koob & Kreek, 
2007; Wise, 2002; Wise & Bozarth, 1987). In the field 
of opiates, since physical dependence appears later 
than the positive motivational effects during chronic 
opiate exposure, great attention has been given to both 
the positive opiate-reinforcing properties that promote 
substance abuse and the negative reinforcing effects 
that elicit craving and induce relapse during withdrawal 
(Koob & Kreek, 2007). Nonetheless, since the 
seminal study of Himmelsbach (1943), the withdrawal 
syndrome from opiates has mainly been linked with the 
negative affective states that precede severe physical 
disturbances after the chronic opiate treatment is broken, 
despite the craving associated with the attempt to avoid 
withdrawal-induced dysphoria. In this respect, we have 
previously shown that withdrawal from morphine elicits 
intense unconditioned fear reactions accompanied by 
significant Fos-protein immunoreactivity in brainstem 
areas that are known to regulate the expression of 
defensive behaviours in animals facing fear-provoking 
stimuli (Castilho, Borelli, Brandao, & Nobre, 2008). 
In another study, we showed that withdrawal from low 
doses of morphine, which has the ability to promote 
slight physical symptoms in rats, increases fear reactions 
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induced by the electrical stimulation of the dorsal aspects 
of the periaqueductal gray (Ávila et al., 2008). 
As revealed by the study of Holmes & Rodgers 
(1999), on initial exposure to the elevated plus-maze 
(EPM), animals acquire information about the entire spatial 
layout of the test and not only about the location of the 
more aversive open arms. With regard to this point, their 
subsequent responses are guided largely by an awareness 
of the location of the relatively safe closed arms. This 
could be one of the reasons why a second exposure to the 
EPM has the ability to inhibit open arm exploration (File, 
Zangrossi, Viana, & Graeff, 1993). In the field of drug 
abuse, however, drug cues could change the preference for 
the safe place for one that signals drug delivery in animals 
submitted to a conflicting place-conditioning procedure in 
which a withdrawn animal learns to associate a non-safe 
region with the positive reinforcing effects of the drug.
In order to go one step further in this matter, this study 
was designed to evaluate whether EPM-experienced 
rats withdrawn from low doses of morphine, in which 
a high anxiety level is the most prominent withdrawal 
symptom, acquire place preference when submitted to a 
conflict paradigm in which drug effects are paired with 
an aversive context: the distal part of the open arms of an 
EPM. Therefore, for our purposes, both the anxiety test 
and place preference conditioning were measured in the 
same apparatus, a biased version of the plus-maze. In order 
to verify the influence of previous EPM spatial learning 
on the performance of morphine-withdrawn rats, half the 
animals in this study experienced the EPM immediately 
before the beginning of the treatment. Additional groups 
were also tested under the influence of morphine.
Methods
Subjects
Male Wistar rats from the animal house of the 
University of São Paulo in Ribeirão Preto, weighing 220–
250 g at the beginning of the experiment, were used. They 
were housed in groups of four in Plexiglas-walled cages 
lined with wood shavings that were changed every three 
days. The animals were kept in a 12:12 dark/light cycle 
(lights on at 07:00 h) at 24 ± 10 C and given free access to 
food and water. Before treatment, the animals had a three-
day habituation period. The experiments reported in this 
article were approved by the local Ethics Committee and 
were performed in compliance with the recommendations 
of the Brazilian Society for Neuroscience and Behaviour 
which, in turn, are in accordance with the rules of the U. 
S. National Institutes of Health Guide for Care and Use 
of Laboratory Animals.
Induction of morphine dependence and withdrawal
Rats withdrawn from a chronic regimen of elevated 
doses of morphine show severe physical alterations 
(Himmelsbach, 1943) that could disguise the expression 
of affective reactions. In fact, withdrawal from opiates in 
rodents is characterized by the expression of a constellation 
of serious somatic signs such as jumping, paw tremor, 
weight loss, diarrhoea and wet dog shake (Bozarth & 
Wise, 1984; Gellert & Holtzman, 1978; Maldonado, 
Stinus, Gold, & Koob, 1992). However, Papaleo and 
Contarino (2006) showed that mice submitted to a six-
day period of increasing morphine doses (i.p, 10–50 mg/
kg) and tested after a 32-hour withdrawal showed no 
differences in global opiate physical withdrawal scores 
when compared with their control groups. Thus, for 
our purposes, morphine dependence was obtained by 
injecting the drug subcutaneously (s.c., 10 mg/ml/Kg) 
twice a day (08:00 and 18:00 h) for 10 days. This is a 
low dose with the ability to selectively promote affective 
signs of withdrawal while avoiding the physical ones 
after treatment interruption (Ávila et al., 2008). The 
last injection was given on the morning of the 10th day. 
Throughout the experiment the animals were gently 
handled on a daily basis for 3 minutes immediately before 
drug administration in order to reduce the stressful effects 
of the injection procedure. Tests were carried out 2 or 48 
hours after the last control or drug injections (2- or 48-h 
groups, respectively). Independent groups of animals 
were used for each experiment.
Drugs
Morphine sulphate (Cristalia, Brazil) was prepared 
for injection in physiological saline (0.9%) and all 
injections were made subcutaneously in a volume 
of 1 ml/kg body weight. The dose used in this study 
was based upon prior work on spontaneous opioid 
withdrawal (Avila et al., 2008).
Elevated plus-maze
In order to study the role of the negative reinforcing 
effects elicited in rats under morphine withdrawal in 
the induction of place preference, both the anxiety test 
and place preference conditioning were measured in 
the same apparatus, a biased version of the plus-maze, 
in a procedure adapted from the study of Salome et al. 
(2004). In addition, to verify the influence of a second 
exposure on conditioning, naïve rats or those previously 
experienced in the EPM were used. 
The EPM apparatus was made of wood and 
consisted of four arms of equal dimensions (50 x 12 
cm). Two arms were enclosed by 40-cm high walls 
and were arranged perpendicularly to two open arms. 
The structure was located inside an insulated room 
with 20 lux of luminosity at the end of the open arms, 
and was elevated 50 cm above the floor, with a 1-cm 
Plexiglas rim surrounding the open arms to prevent falls 
(Pellow, Chopin, File, & Briley, 1985). To allow open-
arm conditioning, a 12 x 20-cm Plexiglas wall divided 
the open arms into two main sections, referred to as 
proximal and distal (in relation to the central section). 
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The animals were confined to these distal parts of the 
maze. This procedure was adapted from the study of 
Salome et al. (2004). The tests were conducted 2 or 48 
hours after the last saline or morphine administration. 
During the pre-exposure drug (2-h) or withdrawal (48-h) 
sessions, the animals were placed in the centre of the 
EPM facing one of the closed arms and their behaviour 
was recorded on video for five minutes. 
Experimental procedures
Two main groups were formed: animals with no 
previous experience in the plus-maze (EPM-naïve) and 
those previously exposed to the EPM before the start of 
chronic drug treatment (EPM-experienced). Each group 
was subdivided and all the animals were conditioned 
during 30 minutes a day for 10 days to the distal parts 
of the open arms of the plus-maze, immediately after 
either saline or morphine injections. The animals 
were exposed daily to one of the two open arms of the 
EPM immediately after each morning injection. This 
procedure allowed us to expose the animals to each 
open arm the same number of times, counterbalancing 
the place preference induced during conditioning. 
Finally, the saline and morphine groups were further 
subdivided into two groups and the animals were 
tested either under the effect of the drug (2-h group) or 
after 48 hours of withdrawal (48-h group). Thus, eight 
independent groups were formed: 2-h saline naïve rats 
(n = 9), 48-h saline naïve rats (n = 10), 2-h morphine 
naïve rats (n = 9), 48-h morphine naïve rats (n = 10), 2-h 
saline experienced rats (n = 9), 48-h saline experienced 
rats (n = 10), 2-h morphine experienced rats (n = 9), and 
48-h morphine experienced rats 48 h (n = 10).
Behavioural measures
The effects of the treatments were quantified 
through the analysis of three types of measures: 
anxiety was inferred from the use of conventional 
measures (percentage of entries and time spent in the 
open arms) and risk-assessment behaviour (frequency 
of stretched-attending postures – SAP, and time spent 
in the centre of the maze) (Cruz, Frei, & Graeff, 
1994; Pellow et al., 1985; Rogers & Johnson, 1995). 
SAP was defined as an exploratory posture in which 
the body of the animal is stretched forward and then 
retracted to the original position without any forward 
locomotion (Holmes & Rodgers, 1999). Place 
preference conditioning was evaluated through the 
analysis of the number of entries, total time spent and 
distance run in the open-arm extremities, which was 
where the animals were conditioned. The number of 
closed-arm entries was taken as an index of locomotor 
activity (Rodgers & Johnson, 1995). Behaviour in the 
plus-maze was recorded with a camera (Everfocus, 
USA) linked to a monitor and video cassette recorder 
placed outside the experimental room.
Statistical analysis
The results are presented as means ± SEM. The data 
obtained in each of the experiments were analyzed by means 
of a three-way factorial ANOVA with the EPM training 
(naïve x experienced), treatment (saline x morphine), and 
condition during the test (under drug effects (2-h) x 48-h 
drug withdrawal) as the main factors. Tukey HSD post-hoc 
comparisons were carried out whenever significant overall 
F-values were obtained. In all cases a probability level of p 
< .05 was considered significant.
Results
Figure 1 shows the percentage of time spent in the 
open arms (top) and the number of open- (middle) and 
Figure 1. Traditional Measures, as indices of anxiety, are presented 
as Means ± SEM. Histograms represent the mean percentage of 
time spent in the open arms (top), percentage of open arms entries 
(middle), and number of closed arms entries (bottom) of rats not 
exposed to (EPM-naïve - left) or with previous experience (EPM-
experienced - right) in the EPM, confined daily, during 10 days, 
to the distal parts of the open-arms immediately after saline or 
morphine s.c. injections. The animals were tested 2- (2-h) or 48-
hours (48-h) after the last injection. Three-way factorial ANOVA 
were carried-out, followed, when appropriate, by post-hoc Tukey 
HSD test; p ≤.05. Each column received a number (1 to 8) in order to 
depict the significant differences, as observed above histograms.
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Figure 2. Histograms represent the Mean ± SEM of the frequency 
of stretching-attending postures (SAP) (top) and the time spent 
in the center of EPM (bottom), taken as measures of Risk-
Assessment behavior of rats not exposed to (EPM-naïve - left) or 
with previous experience (EPM-experienced - right) in the EPM, 
confined daily, during 10 days, to the distal parts of the open-arms 
immediately after saline or morphine s.c. injections. The animals 
were tested 2- (2-h) or 48-hours (48-h) after the last injection. 
Three-way factorial ANOVA were carried-out, followed, when 
appropriate, by post-hoc Tukey HSD test; p ≤.05. As described 
above, each column received a number (1 to 8) in order to depict 
the significant differences, as observed above histograms.
Figure 3. Open-arms measures, as indices of place preference, 
are presented as Mean ± SEM. Histograms represent the mean 
distance run in the open arms (top), and the mean frequency of 
entries (middle) and time spent in open extremities (bottom) 
of rats not exposed to (EPM Naïve - left) or with previous 
experience (EPM-experienced - right) in the EPM, confined 
daily, during 10 days, to the distal parts of the open-arms 
immediately after saline or morphine s.c. injections. The 
animals were tested 2- (2-h) or 48-hours (48-h) after the last 
injection. Three-way factorial ANOVA were carried-out, 
followed, when appropriate, by post-hoc Tukey HSD; p ≤.05. 
The columns received a number (1 to 8) in order to depict the 
significant differences, as observed above histograms.
closed-arm entries (bottom) in the EPM by naïve and 
experienced saline or morphine pre-treated rats tested 
under the effects of morphine or during withdrawal. For 
the percentage of time spent in the open arms, three-
way factorial ANOVA revealed significant effects of 
previous EPM exposure [F(1, 68) = 43.09, p < .0001] 
and treatments [F(1, 68) = 49.24, p < .0001]. No 
significant effects of condition were found. However, 
interactive effects were obtained between treatment and 
plus-maze experience [F(1, 68) = 32.57, p < .0001], 
showing that the development of place conditioning 
depends upon previous EPM spatial learning. Post-hoc 
Tukey comparisons showed that morphine increases the 
time spent in the open arms in rats under the effect of 
morphine or withdrawal. A similar result was obtained 
for the percentage of open-arm entries. ANOVA detected 
main effects of treatment [F(1, 68) = 30.32, p < .0001], 
previous EPM experience [F(1, 68) = 23.68, p < .0001] 
and treatment x EPM skills interaction [F(1, 68) = 14.44, 
p < .0005]. ANOVA also showed significant effects on 
the number of closed-arm entries [treatment: F(1, 68) = 
10.57, p < .0005; condition: F(1, 68) = 4.88, p < .05]. 
Post-hoc tests revealed that this effect was a result of the 
increase in locomotor activity by the rats tested under 
the effect of morphine (2-h), which would account for 
the increase in the percentage of entries and time spent 
in the open arms observed in this group.
With regard to the risk-assessment behaviours 
(Figure 2), ANOVA showed significant differences 
among the groups in both measures, frequency of 
SAP [EPM previous experience: F(1, 68) = 4.47, p 
< .05; condition: F(1, 68) = 8.46, p < .005; treatment 
x condition interaction: F(1, 68) = 4.47, p < .05] and 
time spent at the centre of the EPM [treatment: F(1,68) 
= 37.10, p < .0001; EPM previous exposure: F(1,68) 
Spatial learning and morphine withdrawal in rats 63
= 4.26, p < .05; treatments x EPM skills x condition 
interaction: F(1, 68) = 10.80, p < .005]. EPM-naïve rats 
showed no significant differences compared to control 
animals in any of the measures recorded. Tukey post-
hoc tests showed that the differences obtained were 
due to significant increases in the expression of risk-
assessment behaviours displayed by EPM-experienced 
rats undergoing morphine withdrawal.
The results obtained for the open arms (Figure 3) 
were comparable to those previously described. Indeed, 
no significant results were obtained in EPM-naïve rats, 
regardless of the treatment given (saline or morphine) 
or the testing condition (2-h or 48-h). Again, plus-
maze experience was necessary for the development 
of open-arm place preference in morphine pre-treated 
rats. Post-hoc tests showed that rats tested under the 
effect of morphine (2-h) or during drug withdrawal 
(48-h) increased the distance run in the open arms (top) 
[treatment: F(1, 68) = 47.41, p < .0001; EPM previous 
experience: F(1, 68) = 31.47, p < .0001; treatment x 
EPM interaction: F(1, 68) = 22.68, p <.0001] and the 
number of entries (middle) [treatment: F(1, 68) = 28.27, 
p < .0001; EPM previous experience: F(1, 68) = 19.00, p 
< .0001; treatment x EPM interaction: F(1, 68) = 12.90, p 
< .001] and time spent in open-arm extremities (bottom) 
[treatment: F(1, 68) = 48.71, p < .0001; EPM previous 
experience: F(1, 68) = 45.90, p < .0001; treatment x 
EPM interaction: F(1, 68) = 28.39, p < .001].
Discussion
 In this study we report four main findings. First, 
morphine pre-treated rats, naïve in respect to the overall 
EPM context, did not develop place preference; they 
behaved like control rats. Second, rats that had previous 
experience in the EPM showed no changes in open-arm 
avoidance on a second exposure when compared to naïve 
rats for this condition. Third, previous spatial learning 
of the EPM contextual cues was, in fact, a requirement 
for anxiety-inducing place preference for the open-
arms in morphine-withdrawn rats. Finally, conditioned 
place preference was achieved both in rats under the 
effect of morphine and those in withdrawal, probably 
through the influence of the positive (pleasurable-like 
x context) or negative (anxiety-provoking x context) 
reinforcing effects promoted by the presence or absence 
of the drug in the central nervous system. The former is 
related to the ability of the drug to function as a positive 
reinforcer. With regard to the later, after the interruption 
of chronic exposure, behaviour is guided by the negative 
reinforcing properties elicited by withdrawal.
Drug-induced preference for a specific place cuing for 
drug availability over a neutral place, i.e., the conditioned 
place preference, has long been used as a behavioural 
paradigm indicative of drug-associated memories 
(Sanchis-Segura & Spanagel, 2006). The motivational 
changes associated with continuous drug use result, at 
least in part, from the formation of memories associated 
with drug consumption (Cannon & Bseikri, 2004). In our 
study, we found that familiarity with the plus-maze cues 
was necessary for the development of place preference. In 
this case, it is likely that, during conditioning, animals not 
previously exposed to the EPM remain completely naïve 
in respect to EPM cues, except for the place in which 
they were confined during conditioning, i.e., the distal 
parts of the open-arms. In this case, the drug-associated 
memory formed through repeated drug exposure, which 
motivates the animals to approach the positive reinforcing 
environment, could not be evoked. 
Regarding the effects obtained in rats previously 
exposed to the EPM, the results obtained here do not 
match those observed in previous studies, which claim 
that a second exposure to the EPM enhances open-arm 
avoidance, mainly through a shift from an unconditioned 
to a conditioned form of fear response (Carobrez & 
Bertoglio, 2005; Cruz-Morales, Santos, & Brandao, 
2002; File, 1993; File & Zangrossi, 1993; File et al., 
1993; Pellow et al., 1985;). However, some particular 
characteristics of our study can account for these results. 
It was hypothesized that when the EPM is used to detect 
an extrinsic anxiogenic state, the anxiogenic response 
cannot be modified or antagonized by benzodiazepines 
(File, 1993). On the other hand, a simple exposure to cat 
odour resulted in a generalized anxiety response that was 
easily detected in the plus-maze (Zangrossi & File, 1993), 
an anxiogenic effect counteracted by the benzodiazepine 
chlordiazepoxide even in plus-maze-experienced 
rats (File & Zangrossi, 1993). Similarly, the study of 
Bertoglio and Carobrez (2002) showed that the short-
acting benzodiazepine midazolam retains its efficacy in 
rats confined either to open or enclosed arms compared 
with rats naïve for the test, showing that EPM cues that 
induce anxiety retain their efficacy in EPM-experienced 
rats. In the present study, it is likely that, notwithstanding 
the EPM-experienced rats that had previously been 
submitted to the plus-maze, the intense fear generated by 
daily confinement in the open-arms actually prevented 
the anxiety generated by the EPM cues themselves. 
The temporal factor could also account for the results 
because at least 10 days elapsed between the baseline 
and test exposures. In this case, 10 days of exposure to 
the open-arms, associated with a 10-day interval between 
the baseline and test sessions, might mitigate the initial 
influence of EPM aversive cues on behaviour.
Addiction to opiates is frequently associated with 
the repetitive intake of large amounts concomitant with 
the development of physical dependence. Although the 
current definitions of addiction emphasize its behavioural 
aspects, such as compulsiveness and drug-seeking 
behaviour, opiate addiction is mainly defined by the 
presence of physical dependence (Koob, Maldonado, & 
Stinus, 1992; Maldonado et al., 1992; Schulteis, Heyser, 
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& Koob, 1997; Schulteis, Markou, Gold, Stinus, & 
Koob, 1994; Schulteis, Yackey, Risbrough, & Koob, 
1998; Stinus, Caille, & Koob, 2000). Nonetheless, in a 
previous study we showed that low doses of morphine, 
which characteristically promoted slight physical 
symptoms in morphine-withdrawn rats, elicited intense 
unconditioned fear reactions (Ávila et al., 2008). In 
our study, morphine itself was unable to promote the 
locomotor activation that is commonly observed after 
acute injection in rats naïve for the plus-maze. Indeed, 
none of the measures were altered, showing that morphine 
did not change anxiety levels, ambulation, exploratory 
activity, or risk-assessment behaviour in these animals 
despite a marginally significant difference in the number 
of closed-arm entries. However, even in this case, rats 
under the effects of morphine presented overall fear 
reactions similar to those observed in control rats.
The most important results obtained in the present 
study concern the effects of morphine and its withdrawal 
in rats with prior experience in the EPM, confined to 
the distal parts of the open arms immediately after the 
s.c. drug injections. When the EPM-experienced rats 
were tested under the effects of morphine, an increase in 
the conventional and open-arm scrutiny measures was 
observed, similar to that noted in morphine-withdrawn 
rats. This probably resulted from psychomotor activation 
associated with place conditioning induced by morphine 
positive-reinforcing effects, since the observed risk-
assessment behaviour did not differ significantly from 
those obtained in withdrawn animals. In any case, highly 
addictive drugs, including amphetamine, cocaine, and 
morphine, have the ability to increase motor behaviour, 
an effect mainly attributed to the increase in dopamine 
transmission in the striatal complex (Di Chiara & 
Imperato, 1988; Wise & Bozarth, 1987).
It is well known that an increase in the frequency of 
SAP is a reliable index of anxiety in rodents. Fernández 
Espejo (1997) showed that SAP is one of the best 
indicators of anxiety in the EPM. In addition, Grewal, 
Shepherd, Bill, Fletcher, and Dourish (1997) established 
this response as an important component of the risk-
assessment repertoire of defensive behaviour in rodents. 
The time spent at the centre of the EPM as a reflection 
of anxiety-like behaviour has been discussed in less 
detail. However, in spite of the fact that this measure 
is infrequently recorded in the plus-maze, some authors 
have argued that the time spent at the centre of the EPM 
is possibly related to approach-avoidance conflict (Cruz 
et al., 1992; Rodgers, Lee, & Sheperd, 1992; Trullas & 
Skolnick, 1993), in a way similar to SAP. That is the 
reason why, in our study, both SAP and the time spent 
at the centre of the maze were grouped and taken as 
indices of risk-assessment behaviours.
The probability of facilitating drug addiction in 
humans has been strongly related to the existence 
of multiple comorbid diagnoses, such as depression 
and anxiety disorders (Nadal, Rotllant, Marquez, & 
Armario, 2005). However, the role of the negative 
affective states, elicited during opiate withdrawal in rats, 
and negative-reinforcing properties that induce relapse, 
have not been widely studied. In a previous study we 
showed that rats withdrawn from the benzodiazepine 
diazepam promptly displayed drug-seeking behaviour 
when tested in a place-preference procedure even when, 
during conditioning, drug delivery was preceded by 
an aversive event (Souza-Pinto, Castilho, Brandao, & 
Nobre, 2007). In the present study, rats experiencing the 
positive reinforcing effects of low doses of morphine 
were challenged, in a conflict paradigm, with the 
aversive cues of the open arms of the EPM during 
the place conditioning procedure. In connection with 
this point, opiate dependence, when produced by 
progressive and high doses of morphine, promotes 
extreme physical signs of withdrawal (Frederickson & 
Pinsky, 1975; Wang, Zhao, Xiang, Wang, & Wu, 2004) 
that could mask some overt behavioural elements that 
are commonly used as indices of fear and anxiety, such 
as the measures obtained with the use of the EPM. In 
the present study, we showed that rats withdrawn from 
low doses of morphine acquired strong place preference 
for the region of the maze where they had experienced 
the positive reinforcing effects of the drug, despite 
a continuous degree of aversion, as revealed by the 
increase in the frequency of SAP and in the time spent 
at the centre of the maze. Thus, we argue that previous 
spatial learning in the EPM in morphine pre-treated rats 
is a necessary condition for the development of relapse. 
In other words, overall familiarity with the context 
in which conditioning takes place is required for the 
development of place preference. This phenomenon 
was observed in animals tested under the effect of 
morphine and those withdrawn from this drug, leading 
us to suppose that place preference conditioning in 
both groups was achieved through different processes. 
When under the effect of morphine, rats which showed 
anxiety levels similar to controls probably acquired 
place preference due to the positive reinforcing effects 
of the drug. On the other hand, morphine-withdrawn 
rats acquired a preference for the place where they 
were conditioned through the influence of the negative 
reinforcing effects of withdrawal. 
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